+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rhinovirus Drug"

Rhinovirus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Rhinovirus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Rhinovirus Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Rhinovirus Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 57 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Rhinovirus Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat rhinovirus infections, which are caused by a group of viruses that can cause the common cold. These drugs are typically used to reduce the severity of symptoms, such as nasal congestion, sore throat, and coughing. They may also be used to reduce the duration of the infection. Rhinovirus drugs are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. They may be prescribed by a doctor or purchased over-the-counter. The Rhinovirus Drug market is highly competitive, with many companies offering products to treat rhinovirus infections. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more